A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis

INTRODUCTION: The impact of upadacitinib on rheumatoid arthritis (RA) symptoms was evaluated during the first 12 weeks of treatment via patient-reported outcomes (PROs) using a mobile health application (app). METHODS: Participating rheumatologists from the CorEvitas RA Registry (prospective, observ...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrold, Leslie R., Zueger, Patrick, Nowell, W. Benjamin, Blachley, Taylor, Schrader, Amy, Lakin, Paul R., Curtis, David, Stradford, Laura, Venkatachalam, Shilpa, Tundia, Namita, Patel, Pankaj A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654297/
https://www.ncbi.nlm.nih.gov/pubmed/37728861
http://dx.doi.org/10.1007/s40744-023-00594-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654297/
https://www.ncbi.nlm.nih.gov/pubmed/37728861
http://dx.doi.org/10.1007/s40744-023-00594-6

Ejemplares similares